24 Sep. 2025
The Cell Centre is looking to expand efforts in the GMP production of cell products with a specific focus on immune-monitoring.
The successful applicant is expected to be pivotal co-worker in the development and improvement of immune cell-based therapies for malignant diseases and the preparation of GMP compliant production of cellular products including gene-modified immune cells and monitoring of anti-cancer directed vaccination.
24 September 2025
Nicole explores how moving away from the “domino-chain” view of the brain toward seeing it as a complex dynamical system – full of feedback loops and interactions – is opening doors to exciting new discoveries. They talk about the challenges of measuring brain disorders, why fundamental research is so essential, and how predicting salmon populations can help predict seizures in the brain.
23 September 2025
“The spinal cord isn’t just a passive relay station executing brain commands”, says Susana Lima, Principal Investigator of CF’s Neuroethology Lab and senior author of the study. “It integrates sensory inputs, responds to arousal, and adjusts its output based on the animal’s internal state. It’s much more sophisticated than we imagined”.
Memming Park (Neural Dynamics Lab)
Klaas van Gisbergen (Tissue Immunity Lab)
Champalimaud Foundation Auditorium
Please register via this link.
21 August 2025
With deep sorrow at the passing of Dr. Henrique Nabais, we pay tribute to our colleague and our friend. His unwavering dedication, leadership and professionalism earned him the highest regard and respect from all who knew him. We extend our heartfelt condolences to his family and friends.
Dr. Henrique Nabais led the Gynaecology Unit of the Champalimaud Clinical Centre since 2013. In these years, he left a profound and lasting mark on his colleagues, on the many patients he cared for, and on their families, whose trust he honoured with compassion and excellence.
19 Aug. 2025
[THIS CALL IS NOW CLOSED]
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Lab Manager to join our team at the Champalimaud Research Program.
The Cancer Dormancy & Immunity Lab, led by Dr. Ana Luisa Correia, at Champalimaud Foundation, Lisbon, Portugal, invites applications for the position of Lab Manager.
16 August 2025
An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.